NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
申请人:Warner-Lambert Company LLC
公开号:EP1685115A1
公开(公告)日:2006-08-02
[EN] NOVEL NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS<br/>[FR] NOUVEAUX INHIBITEURS DU RECAPTAGE DE LA NOREPINEPHRINE POUR LE TRAITEMENT DES TROUBLES DU SYSTEME NERVEUX CENTRAL
申请人:WARNER LAMBERT CO
公开号:WO2005042501A1
公开(公告)日:2005-05-12
This invention relates to compounds of the formula (I), wherein R1, R2, and R3 and R4 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
申请人:Caprathe William Bradley
公开号:US20050096327A1
公开(公告)日:2005-05-05
This invention relates to compounds of the formula 1
wherein R
1
, R
2
, and R
3
and R
4
are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.